RecruitingPhase 2 / Phase 3NCT06154252
8
studies recruiting now
as of 7 Sept 2026
44
studies registered in total
as of 7 Sept 2026
21
countries with a recruiting site
as of 7 Sept 2026
5 Aug 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 2NCT07103746
Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
RecruitingPhase 1NCT06371417
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
RecruitingNot applicableNCT06857708
The Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®
RecruitingNCT06877793
Real-Time Diagnosis of Life-Threatening Necrotizing Soft Tissue Infections (NSTI) Using Indocyanine Green (ICG) Kinetic Modeling
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 8 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Necrotizing myositis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Necrotizing myositis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).